Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.
Riccio G, Antonucci S, Coppola C, D'Avino C, Piscopo G, Fiore D, Maurea C, Russo M, Rea D, Arra C, Condorelli G, Di Lisa F, Tocchetti CG, De Lorenzo C, Maurea N. Riccio G, et al. Among authors: de lorenzo c. Front Physiol. 2018 Feb 6;9:38. doi: 10.3389/fphys.2018.00038. eCollection 2018. Front Physiol. 2018. PMID: 29467663 Free PMC article.
A novel human antitumor dimeric immunoRNase.
Riccio G, Borriello M, D'Alessio G, De Lorenzo C. Riccio G, et al. Among authors: de lorenzo c. J Immunother. 2008 Jun;31(5):440-5. doi: 10.1097/CJI.0b013e31816bc769. J Immunother. 2008. PMID: 18463541
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents.
Riccio G, Esposito G, Leoncini E, Contu R, Condorelli G, Chiariello M, Laccetti P, Hrelia S, D'Alessio G, De Lorenzo C. Riccio G, et al. Among authors: de lorenzo c. FASEB J. 2009 Sep;23(9):3171-8. doi: 10.1096/fj.09-131383. Epub 2009 May 5. FASEB J. 2009. PMID: 19417081
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.
Fedele C, Riccio G, Coppola C, Barbieri A, Monti MG, Arra C, Tocchetti CG, D'Alessio G, Maurea N, De Lorenzo C. Fedele C, et al. Among authors: de lorenzo c. Breast Cancer Res Treat. 2012 Jun;133(2):511-21. doi: 10.1007/s10549-011-1783-9. Epub 2011 Sep 27. Breast Cancer Res Treat. 2012. PMID: 21947749
Effects of a human compact anti-ErbB2 antibody on prostate cancer.
Malara AE, Fedele C, Aloj L, Arra C, Laccetti P, D'Alessio G, De Lorenzo C. Malara AE, et al. Among authors: de lorenzo c. Oncol Rep. 2012 Jul;28(1):297-302. doi: 10.3892/or.2012.1760. Epub 2012 Apr 10. Oncol Rep. 2012. PMID: 22505344
Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.
Fedele C, Riccio G, Malara AE, D'Alessio G, De Lorenzo C. Fedele C, et al. Among authors: de lorenzo c. Breast Cancer Res Treat. 2012 Jul;134(2):595-602. doi: 10.1007/s10549-012-2103-8. Epub 2012 Jun 7. Breast Cancer Res Treat. 2012. PMID: 22674190
Effects of a human compact anti-ErbB2 antibody on gastric cancer.
Fedele C, Carvalho S, Riccio G, Paciello R, Laccetti P, Schmitt F, De Lorenzo C. Fedele C, et al. Among authors: de lorenzo c. Gastric Cancer. 2014 Jan;17(1):107-15. doi: 10.1007/s10120-013-0244-z. Epub 2013 Mar 5. Gastric Cancer. 2014. PMID: 23460348
233 results